References
- Papi M., Didona B., De Pita O., Frezzolini A., Di Giulio S., De Matteis W., et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: Cytokine and platelet P‐selectin studies. Arch Dermatol 1998; 134: 447–52
- Calamia K. T., Balabanova M., Perniciaro C., Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation. J Am Acad Dermatol 2002; 46: 133–7
- Jorizzo J. L. Livedoid vasculopathy: What is it?. Arch Dermatol 1998; 134: 491–3
- Wakelin S. H., Ellis J. P., Black M. M. Livedoid vasculitis with anticardiolipin antibodies: Improvement with danazol. Br J Dermatol 1998; 139: 935–7
- Acland K. M., Darvay A., Wakelin S. H., Russell-Jones R. Livedoid vasculitis: A manifestation of the antiphospholipid syndrome?. Br J Dermatol 1999; 140: 131–5
- Boyvat A., Kundakci N., Babikir M. O., Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 2000; 143: 840–2
- Maessen‐Visch M. B., Hamulyak K., Tazelaar D. J., Crombag NH., Neumann HA. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 1999; 135: 41–4
- Federman D. G., Kirsner R. S. An update on hypercoagulable disorders. Arch Intern Med 2001; 161: 1051–6